semaglutide protocol for weight loss Two-year effects of in adults with overweight or obesity: the STEP 5 trial Once-weekly 2.4 mg Semaglutide for

Climacteric 24 , 587592 (2021)

Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1

Your 3D body scan is performed in-office when you choose to come in, and the Styku app lets you track progress from your phone between scans

Using a method known as "target trial emulation," they compared patients initiating GLP-1 drugs with those initiating sodium-glucose cotransporter-2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors

This is especially important if you have any health issues, are pregnant or breastfeeding, or take other medicines